Showing results (81-90 of 203) with videos related to
Sort By:
Pageof 21
Clinical Pharmacology and Therapeutics|January 1, 1983
Test dose for predicting high-dose methotrexate infusionsI G Kerr, J Jolivet, J M Collins, et al.Annals of Internal Medicine|July 1, 1977
Lymphoma presenting in bone: results of histopathology, staging, and therapyR R Reimer, B A Chabner, R C Young, et al.The Journal of Clinical Investigation|March 1, 1985
Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrowS Koizumi, G A Curt, R L Fine, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Immunosuppressive effects of pentostatinE H Kraut, J C Neff, B A Bouroncle, et al.Seminars in Oncology|July 6, 2000
Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemiaJ K Waselenko, M R Grever, M Beer, et al.Cancer Research|October 15, 1990
Immunological effects of flavone acetic acidP L Triozzi, J J Rinehart, L Malspeis, et al.Journal of the National Cancer Institute|May 18, 1988
Phase I clinical investigation of fludarabine phosphate by a loading-dose and continuous-infusion scheduleJ M Leiby, M R Grever, A E Staubus, et al.Cancer|May 1, 1978
Diffuse histiocytic lymphoma involving the gastrointestinal tractK R Hande, R I Fisher, V T DeVita, et al.The Journal of Biological Chemistry|August 15, 1985
Enhanced inhibition of thymidylate synthase by methotrexate polyglutamatesC J Allegra, B A Chabner, J C Drake, et al.Cancer|August 1, 1978
Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapyR C Young, G P Canellos, B A Chabner, et al.Pageof 21